The use of spirocyclic scaffolds in drug discovery

被引：835

作者：

Zheng, Yajun ^{[1
]}

Tice, Colin M. ^{[1
]}

Singh, Suresh B. ^{[1
]}

机构：

[1] Vitae Pharmaceut Inc, Ft Washington, PA 19034 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 16期

关键词：

Spirocyclic; Scaffold; Drug discovery; 1; BACE1; INHIBITORS; MACROCYCLIC INHIBITORS; UREA DERIVATIVES; RECEPTOR LIGANDS; INVERSE AGONISTS; POTENT; DESIGN; OPTIMIZATION; BETA; IDENTIFICATION;

D O I：

10.1016/j.bmcl.2014.06.081

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery. In this brief review, we highlight selected examples from the primary medicinal chemistry literature during the last three years to demonstrate the versatility of spiro scaffolds. With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery. (C) 2014 The Authors. Published by Elsevier Ltd.

引用

页码：3673 / 3682

页数：10

共 50 条

[41] Tetrahydropyrido[d]pyridazinones-promising scaffolds for drug discovery
Yaremenko, Anatoliy G.
Volochnyuk, Dmitriy M.
Shelyakin, Vyacheslav V.
Grygorenko, Oleksandr O.
TETRAHEDRON, 2013, 69 (33) : 6799 - 6803
[42] Enantiomeric separation of chiral scaffolds and cores used in drug discovery
Wilcox, Melissa
Lerner, Claude
Anderson, Scott
Szczerba, Ted
Lowden, Gay
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[43] An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery
He, Min
Fan, Meiyan
Peng, Zhiyun
Wang, Guangcheng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 221
[44] Drug metabolism assays and their use in drug discovery
Bayliss, MK
Eddershaw, R
PHARMACOKINETIC CHALLENGES IN DRUG DISCOVERY, 2002, 37 : 69 - 79
[45] Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery
Li, Junjie
Zhao, Rui
Miao, Peiran
Xu, Fengfeng
Chen, Jiahao
Jiang, Xiaoying
Hui, Zi
Wang, Liwei
Bai, Renren
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 260
[46] Synthesis of spirocyclic scaffolds using hypervalent iodine reagents
Singh, Fateh V.
Kole, Priyanka B.
Mangaonkar, Saeesh R.
Shetgaonkar, Samata E.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2018, 14 : 1778 - 1805
[47] Aryl Urea Based Scaffolds for Multitarget Drug Discovery in Anticancer Immunotherapies
Martin-Beltran, Celia
Gil-Edo, Raquel
Hernandez-Ribelles, German
Agut, Raul
Mari-Mezquita, Pilar
Carda, Miguel
Falomir, Eva
PHARMACEUTICALS, 2021, 14 (04)
[48] Privileged heterocyclic scaffolds in chemical biology and drug discovery: synthesis and bioactivity
Altomare, Cosimo Damiano
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2017, 53 (03) : 239 - 239
[49] Privileged Scaffolds in Drug Discovery. 1st Edition
Yu, B.
Li, N.
Fu., C.
ANTICANCER RESEARCH, 2023, 43 (11)
[50] A focus on the discovery of potent and selective cyclic peptide scaffolds for drug development
Saunders, George J.
Yudin, Andrei K.
CHEMICAL SCIENCE, 2022, 13 (44) : 12942 - 12944

← 1 2 3 4 5 →